IFP Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Buy |
+1
| New | +$1 | ﹤0.01% | 4906 |
|
|
2024
Q2 | – | Sell |
-150
| Closed | -$360 | – | 3291 |
|
|
2024
Q1 | $360 | Buy |
+150
| New | +$360 | ﹤0.01% | 3004 |
|
|
2023
Q1 | – | Sell |
-2,000
| Closed | -$25K | – | 4004 |
|
|
2022
Q4 | $25K | Buy |
+2,000
| New | +$25K | ﹤0.01% | 2717 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4061 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3816 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3731 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3585 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3458 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3306 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3262 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3296 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3402 |
|
|
2019
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2942 |
|
|
2018
Q2 | – | Sell |
-300
| Closed | -$3K | – | 3932 |
|
|
2018
Q1 | $3K | Hold |
300
| – | – | ﹤0.01% | 3387 |
|
|
2017
Q4 | $3K | Sell |
300
-1,822
| -86% | -$18.2K | ﹤0.01% | 3386 |
|
|
2017
Q3 | $26K | Sell |
2,122
-55
| -3% | -$674 | ﹤0.01% | 2407 |
|
|
2017
Q2 | $36K | Sell |
2,177
-470
| -18% | -$7.77K | ﹤0.01% | 2165 |
|
|
2017
Q1 | $38K | Buy |
2,647
+2,625
| +11,932% | +$37.7K | ﹤0.01% | 2067 |
|
|
2016
Q4 | $0 | Sell |
22
-14,252
| -100% | – | ﹤0.01% | 4036 |
|
|
2016
Q3 | $258K | Buy |
+14,274
| New | +$258K | 0.01% | 876 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | – | – | 4043 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2963 |
|